Zelira Therapeutics Ltd (ZLD) — Capital Reinvestment Ratio
Latest as of December 2015:
0.23x
Zelira Therapeutics Ltd (ZLD) has a Capital Reinvestment Ratio of 0.23x as of December 2015, meaning it reinvests 0% of its operating cash flow (AU$159.61K) in capital expenditures (AU$36.80K). See Zelira Therapeutics Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.23x
Capex / Operating Cash Flow
Operating Cash Flow
AU$159.61K
AUD
Capital Expenditures
AU$36.80K
AUD
Data as of
Dec 2015
Most recent filing
Zelira Therapeutics Ltd Capital Reinvestment Ratio (2011–2011)
This chart tracks Zelira Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Zelira Therapeutics Ltd (2011–2011)
Year-by-year Capital Reinvestment Ratio for Zelira Therapeutics Ltd from 2011 to 2011. For live market cap and broader valuation context, see market value of Zelira Therapeutics Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 0.14x | AU$101.92K | AU$13.95K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow